

Expectorant
Symptomatic therapy of cough, accompanied by obstructed sputum discharge.
5 ml of syrup contain:
active ingredient: guaifenesin - 100.0 mg;
excipients: levomenthol - 1.10 mg, glucose solution 3492.0 mg, sucrose - 999.0 mg, ethanol 96% - 0.2595 ml, glycerol - 197.0 mg, sodium citrate - 57.0 mg, sodium saccharinate - 15.0 mg, sodium benzoate - 10.0 mg, citric acid monohydrate - 12.0 mg, caramel dye - 6.75 mg, natural sweetener - 2.50 mg, raspberry flavor - 2.28 mg, carbomer 974P - 0,250 mg, crimson dye [Ponso 4R] - 0,250 mg, purified water - qs to 5 ml.
No customer reviews for the moment.
For oral use. Adults and children over 12 years old: fill the measuring cup to the 10 ml mark and take 10 ml (200 mg of guaifenesin) 4 times a day. The maximum daily dose is 40 ml (800 mg guaifenesin).
Adverse reactions identified during post-registration use of the drug were classified as follows: very frequent (≥1 / 10), frequent (≥1 / 100,
Violations of the gastrointestinal tract. Very rarely: abdominal pain, diarrhea, nausea, vomiting.
Immune system disorders. Very rarely: hypersensitivity reactions (including itching and urticaria), rash.
Nervous system disorders. Very rarely: dizziness, headache, drowsiness.
Hypersensitivity to any of the components of the drug, peptic ulcer and 12 duodenal ulcers in the acute stage, children up to 12 years. Breastfeeding period. Surase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption.
Carefully:
Pregnancy, severe violations of the liver or kidneys, diabetes.
Concurrent use with antitussive drugs, including codeine-containing drugs, is not recommended.
Compatible with bronchodilators, antibacterial agents and other drugs taken in the treatment of bronchopulmonary diseases.
Data on the use of the drug "Gekso Bronkho" in pregnant women is not enough. Therefore, it is not recommended to use the drug during pregnancy, except in cases where the expected benefit to the mother outweighs the potential risk to the fetus. Data on the penetration of guaifenesin into breast milk are not available, so breastfeeding should be stopped for the period of treatment.
You should not take the drug for the treatment of persistent or chronic cough, cough for bronchial asthma and cough, accompanied by excessive secretion of sputum, except in cases where the use of the drug recommended by a doctor.
If, after 3-5 days of taking the drug, the cough persists or there is a fever, cough, rash, prolonged headache, you should consult with your doctor.
Information for patients with diabetes mellitus: the content of carbohydrates in a single dose of the drug corresponds to 0.75 bread unit (XE).
The drug "Gexo Broncho" contains ethanol 96% (0.5 ml / 10 ml syrup). The content of ethanol should be considered for patients suffering from alcoholism, women during pregnancy and breastfeeding, children and persons belonging to high-risk groups, such as patients with liver diseases, epilepsy, brain injury, brain diseases.
The guaifenesin metabolite may cause a color change in the determination of 5-hydroxyindolecetic acid and vanillyl almond acid in urine. Reception of the drug should be stopped 24 hours before urine collection for this analysis.
If the medicinal product has fallen into disrepair or the expiration date has expired, do not pour it into sewage or throw it on the street! Put the medicine in the bag and put it in the trash. These measures will help protect the environment!
Impact on the ability to drive trans. Wed and fur .:
During therapy with Hexo Broncho, care must be taken when driving and working with other technical devices that require increased concentration and psychomotor speed, due to the possibility of dizziness and ethanol content.
Symptoms of an overdose are abdominal discomfort (heartburn, nausea, vomiting), drowsiness.
Treatment is symptomatic and supportive.
Studies and clinical trials of Guaifenesin (Click to expand)